首页> 美国卫生研究院文献>The Journal of Biophysical and Biochemical Cytology >Cooperative effect of TNFalpha bFGF and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
【2h】

Cooperative effect of TNFalpha bFGF and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity

机译:TNFalphabFGF和VEGF对纤维蛋白基质中人微血管内皮细胞的管状结构形成的协同作用。尿激酶活性的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In angiogenesis associated with tissue repair and disease, fibrin and inflammatory mediators are often involved. We have used three- dimensional fibrin matrices to investigate the humoral requirements of human microvascular endothelial cells (hMVEC) to form capillary-like tubular structures. bFGF and VEGF165 were unable to induce tubular structures by themselves. Simultaneous addition of one or both of these factors with TNFalpha induced outgrowth of tubules, the effect being the strongest when bFGF, VEGF165, and TNFalpha were added simultaneously. Exogenously added u-PA, but not its nonproteolytic amino-terminal fragment, could replace TNFalpha, suggesting that TNFalpha-induced u-PA synthesis was involved. Soluble u-PA receptor (u- PAR) or antibodies that inhibited u-PA activity prevented the formation of tubular structures by 59-99%. epsilon-ACA and trasylol which inhibit the formation and activity of plasmin reduced the extent of tube formation by 71-95%. TNFalpha or u-PA did not induce tubular structures without additional growth factors. bFGF and VEGF165 enhanced of the u- PAR by 72 and 46%, but TNFalpha itself also increased u-PAR in hMVEC by 30%. Induction of mitogenesis was not the major contribution of bFGF and VEGF165 because the cell number did not change significantly in the presence of TNFalpha, and tyrphostin A47, which inhibited mitosis completely, reduced the formation of tubular structures only by 28-36%. These data show that induction of cell-bound u-PA activity by the cytokine TNFalpha is required in addition to the angiogenic factors VEGF165 and/or bFGF to induce in vitro formation of capillary-like structures by hMVEC in fibrin matrices. These data may provide insight in the mechanism of angiogenesis as occurs in pathological conditions.
机译:在与组织修复和疾病相关的血管生成中,经常涉及纤维蛋白和炎性介质。我们已经使用三维纤维蛋白矩阵来研究人类微血管内皮细胞(hMVEC)形成毛细管状管状结构的体液需求。 bFGF和VEGF165本身不能诱导管状结构。同时将这些因子中的一种或两种与TNFα诱导引起的小管增生相结合,当同时添加bFGF,VEGF165和TNFalpha时,效果最强。外源添加u-PA,但不能取代其非蛋白水解的氨基末端片段,可以替代TNFalpha,这表明涉及TNFalpha诱导的u-PA合成。可溶性u-PA受体(u-PAR)或抑制u-PA活性的抗体可阻止肾小管结构形成59-99%。抑制纤溶酶形成和活性的epsilon-ACA和trasylol将管形成的程度降低了71-95%。没有其他生长因子,TNFalpha或u-PA不会诱导管状结构。 bFGF和VEGF165将u-PAR分别提高了72%和46%,但是TNFalpha本身也使hMVEC中的u-PAR增加了30%。有丝分裂发生的诱导不是bFGF和VEGF165的主要贡献,因为在TNFα的存在下细胞数目没有明显变化,而完全抑制有丝分裂的酪氨酸磷酸化酶A47仅使肾小管结构的形成减少了28-36%。这些数据表明,除了血管生成因子VEGF165和/或bFGF之外,还需要由细胞因子TNFα诱导细胞结合的u-PA活性,以通过hMVEC在纤维蛋白基质中诱导毛细血管样结构的体外形成。这些数据可以提供病理状态下发生血管生成的机理的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号